Back to search results

Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Metastatic Uveal Melanoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Moffitt Cancer Center, Tampa, Florida, United States

    Contact: Principal Investigator (Jonathan Zager, MD, FACS)
    Joseph Markowitz, MD, PHD (Sub-investigator)
    Nikhil Khushalani, MD (Sub-investigator)
    Lilit Karapetyan, MD, MS (Sub-investigator)
    Andrew Brohl, MD (Sub-investigator)
    Zeynep Eroglu, MD (Sub-investigator)
    Matthew Perez, MD (Sub-investigator)
    Ahmad Tarhini, MD, PhD (Sub-investigator)
Study leads

  • Jonathan Zager, MD, FACS

    Principal Investigator

    Moffitt Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)